We at Insider Monkey have gone over 738 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio positions as of March 31st. In this article, we look at what those funds think of Amedisys Inc (NASDAQ:AMED) based on that data. Is Amedisys Inc (NASDAQ:AMED) a splendid stock to buy now? Hedge funds are becoming less confident. The number of bullish hedge fund positions fell by 6 in recent months. Our calculations also showed that amed isn't among the 30 most popular stocks among hedge funds.